Intrexon





Ebitda Veränderung Datum
Agenus USD -10.11M 19.02M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 506.92M 74.6M 2025-09
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 20.9M 61.44M 2025-06
MacroGenics USD 21.95M 55.39M 2025-09
MannKind USD 9.75M 17.66M 2025-06
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.88B 290M 2025-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 12.68B 2.36B 2024-06
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Veracyte USD 39.73M 3.96M 2025-09
Xencor USD -30.52M 6.39M 2025-06


Intrexon - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.